Day 2

know more about us

DAY 2 - FRIDAY, 19 February 2021

Session 2: Bench and Bedside PAH Science

Chair: Yuriy M. Sirenko – Ukraine

14:00 – 14:20 | Restoring Balance Between the Growth-Promoting and the Growth-
                         Inhibiting Pathways: The PULSAR Sotatercept Study in PAH
                         Marc Humbert – France

 

14:20 – 14:40 | PH Phenotype: Where do we Stand?
                         Raed Dweik – USA

 

14:40 – 15:00 | RV Remodeling; Should it be a Target for Therapy
                         Anton Vonk Noordegraaf – Netherland

 

15:00 – 15:20 | Q & A Panel Discussion

15:20 – 15:40 BREAK

Session 3: Clinical PH

Chair: Khalid S. Al Najashi – KSA

15:40 – 16:00 | PH Outcome Prediction; Risk Stratification
                         Bader Alghamdi – KSA

 

16:00 – 16:20 | Intensification of Therapy; the Role of Combination (Double – Triple)
                         Nazzareno Galiè – Italy

 

16:20 – 16:50 | Debate: Switching Between PH Drugs.
                         Pro: Marius Hoeper – Germany
                         Con: Olivier Sitbon – France

 

16:50 -17:10 | Q & A Panel Discussion

17:10 – 17:30 BREAK

Session 4: Current Status of PH in the Region

Chair: Nasser Al Busaidi – Oman

17:30 – 17:50 | PH in Saudi Arabia; Key Points from Local Registries
                         Abdullah Aldalaan – KSA

 

18:30 – 19:00 | PH Challenges in the Developing World
                         Majdy Idrees – KSA

 

18:10 – 18:30 | PH Status in Egypt; Local Experience
                         Mostafa Elshazly – Egypt

 

19:40 – 20:00 | Q & A Panel Discussion